Key result
High ANGPTL4 expression links to advanced stage, lymphatic metastasis, angiogenesis, and poor TSCC survival.
Why the study?
ANGPTL4 and microvessel density may be novel indicators for tumor metastasis in tongue squamous cell carcinoma, but their expression and function remain unclear.
Does the downregulation of ANGPTL4 inhibit migration and proliferation in tongue squamous cell carcinoma?
Observational (n=65)
Does the downregulation of ANGPTL4 inhibit migration and proliferation in tongue squamous cell carcinoma?
Answers are grounded in this paper and cite their sources.
ANGPTL4 is associated with tumor stage, metastasis, and poor survival in TSCC, and its downregulation inhibits cancer cell migration and proliferation, suggesting it may be a novel biomarker and therapeutic target.
OBJECTIVE: Tongue squamous cell carcinoma (TSCC) is the most common malignant cancer in the oral cavity, with a high rate of metastasis to the neck lymphoid node. Angiopoietin-like protein 4 (ANGPTL4) and microvessel density (MVD) may be novel indicators for tumor metastasis. The aim of the present study was to investigate the expression and function of ANGPTL4 in TSCC and the relationship between ANGPTL4 and MVD. METHODS: The expression levels of ANGPTL4 and MVD (CD34) were analyzed in 65 TSCC specimens and the adjacent non-cancerous tissues using immunohistochemistry (IHC). siRNA was delivered into TSCCA cells to downregulate ANGPTL4 expression. Subsequently, validation with real-time RT-PCR and western blot analyses was performed to analyze ANGPTL4 expression levels. In addition, a proliferation assay, migration and invasion assays were carried out. RESULTS: ANGPTL4 expression was associated with tumor stage, lymph node metastasis and MVD expression. Cox regression analysis showed that high levels of ANGPTL4 expression were closely associated with poor survival time. In vitro analyses using qRT-PCR and western blot confirmed that ANGPTL4 was successfully inhibited in TSCCA cells. Suppressing ANGPTL4 resulted in the inhibition of cell proliferation and migration, but neither invasion nor cisplatin resistance was significantly affected. CONCLUSION: High expression levels of ANGPTL4 are associated with the T stage, lymphatic metastasis, angiogenesis and poor overall survival in TSCC patients. The downregulation of ANGPTL4 inhibits the migration and proliferation of cells in TSCC. Taken together, ANGPTL4 may serve as a novel biomarker and therapeutic target for TSCC.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2016) conducted an observational in Tongue squamous cell carcinoma (TSCC) (n=65). ANGPTL4 expression vs. Low expression / adjacent non-cancerous tissues was evaluated on Overall survival, tumor stage, lymph node metastasis, and in vitro cell proliferation/migration. High ANGPTL4 expression was associated with advanced tumor stage, lymphatic metastasis, angiogenesis, and poor overall survival in TSCC patients.
Synapse has enriched 10 related papers. Consider them for comparative context: